Thomas Stricker
We are interested in understand how mutations in transcription factors and chromatin remodeling enzymes contribute to malignancy. We are also interested in the genomic landscape of cancers, and how both permanent and transient alteration in the enhancer landscape contribute to malignancy.
We are interested in understand how mutations in transcription factors and chromatin remodeling enzymes contribute to malignancy. We are also interested in the genomic landscape of cancers, and how both permanent and transient alteration in the enhancer landscape contribute to malignancy.
Keywords: cancer , breast cancer , genomics , epigenetic , transcriptional regulation , enhancer biology
Research Area: Gene Regulation , Genomics , Cancer Biology